Tag: GNI Group
GNI Group to stop patient enrolment in F351 phase 2 liver fibrosis trial
Japanese biotech company GNI Group will end enrolment of new patients for a phase 2 liver fibrosis trial of its drug candidate F351 in China ... Read More
Japanese biotech company GNI Group will end enrolment of new patients for a phase 2 liver fibrosis trial of its drug candidate F351 in China ... Read More